Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TECH

Bio-Techne Corp

Sep 17 • 01:42PM ET

75.46

Dollar change +0.70
Percentage change 0.93	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO VB VBK SPY IVV RSP XLV IBB VHT

Scroll to Statements

Index	S&P 500	P/E	72.23	EPS (ttm)	1.04	Insider Own	1.06%	Shs Outstand	158.22M	Perf Week	2.27%
Market Cap	11.97B	Forward P/E	34.72	EPS next Y	2.17	Insider Trans	-1.18%	Shs Float	156.97M	Perf Month	1.26%
Income	168.08M	PEG	6.42	EPS next Q	0.38	Inst Own	99.39%	Short Float	2.08%	Perf Quarter	0.86%
Sales	1.16B	P/S	10.33	EPS this Y	4.74%	Inst Trans	1.96%	Short Ratio	3.32	Perf Half Y	4.98%
Book/sh	13.08	P/B	5.77	EPS next Y	17.23%	ROA	6.06%	Short Interest	3.27M	Perf Year	2.45%
Cash/sh	0.96	P/C	78.31	EPS next 5Y	11.25%	ROE	8.33%	52W Range	51.79 - 85.57	Perf YTD	-2.21%
Dividend Est.	0.25 (0.34%)	P/FCF	50.70	EPS past 5Y	11.13%	ROI	6.79%	52W High	-11.82%	Beta	1.27
Dividend TTM	0.32 (0.42%)	Quick Ratio	2.75	Sales past 5Y	10.61%	Gross Margin	66.70%	52W Low	45.70%	ATR (14)	2.22
Dividend Ex-Date	Aug 19, 2024	Current Ratio	3.87	EPS Y/Y TTM	-41.27%	Oper. Margin	21.42%	RSI (14)	56.40	Volatility	2.94% 2.83%
Employees	3100	Debt/Eq	0.20	Sales Y/Y TTM	1.97%	Profit Margin	14.50%	Recom	1.62	Target Price	83.17
Option/Short	Yes / Yes	LT Debt/Eq	0.20	EPS Q/Q	-45.81%	Payout	30.61%	Rel Volume	0.37	Prev Close	74.76
Sales Surprise	-0.13%	EPS Surprise	-0.99%	Sales Q/Q	1.59%	Earnings	Aug 07 BMO	Avg Volume	983.42K	Price	75.46
SMA20	3.73%	SMA50	0.70%	SMA200	3.25%	Trades		Volume	243,055	Change	0.93%

Date	Action	Analyst	Rating Change	Price Target Change
May-22-24	Downgrade	Citigroup	Buy → Neutral	$85
Feb-08-24	Initiated	Scotiabank	Sector Outperform	$80
Feb-02-24	Downgrade	Stifel	Buy → Hold	$65
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89
Aug-25-22	Initiated	Credit Suisse	Outperform	$465
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$370
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$600
Mar-08-21	Upgrade	Stephens	Equal-Weight → Overweight	$380 → $425
Feb-23-21	Upgrade	Stifel	Hold → Buy	$435
Jan-25-21	Reiterated	The Benchmark Company	Buy	$320 → $410
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight	$340
Sep-30-20	Initiated	Atlantic Equities	Overweight	$365
Jul-15-20	Downgrade	Stephens	Overweight → Equal-Weight
May-27-20	Downgrade	Stifel	Buy → Hold	$245 → $260
May-14-20	Initiated	The Benchmark Company	Buy	$290

Show Previous Ratings

Today 07:00AM	Verismo Therapeutics Awarded a ScaleReady G-Rex Grant (PR Newswire)
07:00AM	ScaleReady announces a G-Rex Grant has been awarded to Verismo Therapeutics (PR Newswire)
Sep-16-24 07:00AM	ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex Manufacture of CAR-T and TCR Therapies (PR Newswire)
Sep-09-24 05:11AM	Heres What Dragged Bio-Techne Corporation (TECH)? (Insider Monkey)
Aug-27-24 07:00AM	ScaleReady announces the inaugural G-Rex Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine (PR Newswire)
07:00AM	Loading…
Aug-26-24 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES (PR Newswire)
Aug-23-24 01:04AM	Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) (GuruFocus.com)
Aug-08-24 02:28PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Aug-07-24 07:20PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -9.51%
06:30AM	BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Jul-31-24 07:00AM	BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM (PR Newswire)
Jul-29-24 07:00AM	BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO (PR Newswire)
Jul-15-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Jul-12-24 06:58PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
06:00AM	Loading…
Jul-09-24 06:00AM	7 Cheap Biotech Stocks With Major Upside Potential (InvestorPlace)
Jul-02-24 07:06PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
May-31-24 07:00AM	BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES (PR Newswire)
May-30-24 07:00AM	BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex SYSTEM AT THE ANNUAL ASMS CONFERENCE (PR Newswire)
May-29-24 07:00AM	ScaleReady Announces $20 Million G-Rex Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing (PR Newswire)
May-23-24 10:26AM	Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1 (Insider Monkey)
07:00AM	BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE (PR Newswire)
May-22-24 07:00AM	BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY (PR Newswire)
May-20-24 01:34PM	7 Biotech Stocks That Could Breathe New Life Into Your Portfolio (InvestorPlace)
May-14-24 04:49AM	Bio-Techne Corporation (TECH) Declined on Weak Q4 Results (Insider Monkey)
May-08-24 07:00AM	BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 (PR Newswire)
May-07-24 07:00AM	BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) (PR Newswire)
May-06-24 05:57AM	Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating (MT Newswires)
May-02-24 11:40AM	Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript (Insider Monkey)
11:31AM	UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating (MT Newswires)
10:49AM	Loading…
10:49AM	Leerink Partners Adjusts Price Target on Bio-Techne to $95 From $85 (MT Newswires)
10:34AM	Scotiabank Adjusts Price Target on Bio-Techne to $83 From $80 (MT Newswires)
08:17AM	RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept (MT Newswires)
08:00AM	Baird Adjusts Bio-Techne Price Target to $81 From $73 (MT Newswires)
03:11AM	Bio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market ... (GuruFocus.com)
May-01-24 04:54PM	S&P 500 Gains and Losses Today: CVS Falls as Health Care Costs Pressure Profits (Investopedia) +16.22%
02:05PM	Top Midday Gainers (MT Newswires)
01:52PM	Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Heres Why. (Barrons.com)
12:08PM	Update: Bio-Techne Shares Jump After Fiscal Q3 Beat (MT Newswires)
11:10AM	Deutsche Bank Adjusts Price Target on Bio-Techne to $84 From $82 (MT Newswires)
09:30AM	Techne (TECH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:36AM	Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise (MT Newswires)
07:51AM	Bio-Techne Corp (TECH) Q3 Fiscal 2024 Earnings: Mixed Results Amid Market Challenges (GuruFocus.com)
07:40AM	Techne (TECH) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:29AM	Bio-Techne beats third-quarter estimates on improving demand for biotech products (Reuters)
06:30AM	BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Apr-30-24 07:00AM	BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS (PR Newswire)
Apr-29-24 10:38AM	Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific (MT Newswires)
09:39AM	RBC Capital Adjusts Price Target on Bio-Techne to $71 From $79 (MT Newswires)
07:00AM	BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC (PR Newswire)
Apr-26-24 07:00AM	BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY (PR Newswire)
Apr-24-24 10:01AM	Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-23-24 07:00AM	BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS (PR Newswire)
Apr-10-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Apr-08-24 07:00AM	BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY (PR Newswire)
Apr-03-24 07:00AM	BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE (PR Newswire)
Apr-01-24 07:00AM	BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS (PR Newswire)
Mar-28-24 09:00AM	BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES (PR Newswire)
08:39AM	3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition (InvestorPlace)
Mar-22-24 07:00AM	BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA (PR Newswire)
Mar-18-24 08:01PM	7 Biotech Stocks Ready to Ride the Sectors Resurgence (InvestorPlace)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-12-24 07:00AM	BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM (PR Newswire)
Mar-11-24 07:00PM	Director Roeland Nusse Sells 10,400 Shares of Bio-Techne Corp (TECH) (GuruFocus.com)
Mar-06-24 07:00AM	BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Feb-23-24 06:15AM	What Makes Bio-Techne Corporation (TECH) an Investment Bet? (Insider Monkey)
Feb-13-24 08:00AM	The 3 Best Biotech Stocks to Buy in February 2024 (InvestorPlace)
Feb-02-24 10:47AM	Bio-Techne Corporation (NASDAQ:TECH) Q2 2024 Earnings Call Transcript (Insider Monkey)
04:45AM	Q2 2024 Bio-Techne Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-01-24 12:57PM	Bio-Techne Corp (TECH) Reports Mixed Q2 Fiscal 2024 Results Amid Industry Headwinds (GuruFocus.com)
07:51AM	Bio-Techne misses quarterly estimates on persistently weak demand in China (Reuters)
07:07AM	Bio-Techne Q2 Results Miss Estimates; Declares Dividend (RTT News)
06:30AM	BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Jan-29-24 07:00AM	BIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS (PR Newswire)
Jan-25-24 07:00AM	LUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH WITH THE LAUNCH OF THE FIRST FULLY AUTOMATED, SAME-SECTION, HYPERPLEX MULTIOMICS APPLICATION (PR Newswire)
Jan-24-24 07:00AM	SCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN PROTEIN BIOTHERAPEUTIC CHARGE HETEROGENEITY CHARACTERIZATION USING THE MauriceFlex SYSTEM (PR Newswire)
Jan-21-24 01:16PM	3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024 (InvestorPlace)
Jan-16-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Jan-05-24 07:00AM	BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT (PR Newswire)
Jan-04-24 07:00AM	BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024 (PR Newswire)
Dec-21-23 07:00AM	BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Dec-20-23 07:00AM	BIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR EXCELLERATE GMP IPSC EXPANSION MEDIUM SUPPORTING STEM CELL THERAPY (PR Newswire)
Dec-14-23 07:00AM	LUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP INNOVATIVE AI-BASED ASSAY DEVELOPMENT TOOLS (PR Newswire)
Dec-01-23 01:32AM	Should You Hold Bio-Techne Corporation (TECH) For the Long Term? (Insider Monkey)
Nov-27-23 07:00AM	BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE (PR Newswire)
Nov-13-23 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES (PR Newswire)
Nov-02-23 07:00AM	ASURAGEN TO PRESENT NOVEL CLINICAL TESTING DATA AT AMP 2023 CONFERENCE (PR Newswire)
Nov-01-23 10:44AM	Bio-Techne Corporation (NASDAQ:TECH) Q1 2024 Earnings Call Transcript (Insider Monkey)
Oct-31-23 07:53AM	Bio-Techne Corp (TECH) Reports 2% Organic Revenue Growth in Q1 FY2024 (GuruFocus.com)
07:27AM	Bio-Techne's quarterly profit misses estimates as biotech funding woes persist (Reuters)
06:30AM	BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Oct-25-23 03:42PM	3 AI Stock-Split Stocks to Buy Now (InvestorPlace)
09:00AM	LEADING RESEARCH INSTITUTES TO PRESENT NEW DATA USING LUNAPHORE'S COMET TECHNOLOGY AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 38th ANNUAL MEETING (PR Newswire)
Oct-22-23 10:30AM	Bearish Bets: 3 Stocks You Definitely Should Think About Shorting This Week (TheStreet.com)
Oct-20-23 05:01AM	Various Headwinds Pressured Bio-Techne Corporation (TECH) Shares in Q3 (Insider Monkey)
Oct-19-23 07:00AM	BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER (PR Newswire)
Oct-16-23 07:00AM	BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY (PR Newswire)

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HIGGINS JOHN L	Director	Sep 12 '24	Option Exercise	22.95	6,000	137,700	48,608	Sep 16 04:18 PM
Kelderman Kim	Chief Executive Officer	Aug 29 '24	Option Exercise	66.97	1,492	99,919	41,434	Sep 03 04:05 PM
Bohnen Shane	SVP - General Counsel	Aug 15 '24	Option Exercise	0.00	49	0	1,696	Aug 19 05:28 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Option Exercise	22.95	16,000	367,200	59,401	Aug 12 04:08 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Sale	72.10	16,000	1,153,664	43,401	Aug 12 04:08 PM
ROBERT V. BAUMGARTNER	Director	Aug 08 '24	Proposed Sale	72.10	16,000	1,153,664		Aug 08 04:13 PM
Hippel James	CFO	Aug 02 '24	Option Exercise	31.26	53,000	1,656,780	136,002	Aug 06 04:23 PM
Kelderman Kim	Chief Executive Officer	Jul 31 '24	Option Exercise	37.70	14,000	527,800	49,421	Aug 02 04:17 PM
Hippel James	CFO	Jul 23 '24	Option Exercise	31.26	35,000	1,094,100	107,284	Jul 25 04:31 PM
HIGGINS JOHN L	Director	Jul 08 '24	Option Exercise	22.95	6,000	137,700	42,608	Jul 10 04:35 PM
HIGGINS JOHN L	Director	May 14 '24	Option Exercise	22.95	4,000	91,800	40,608	May 16 04:17 PM
HIGGINS JOHN L	Director	May 14 '24	Sale	83.84	4,000	335,377	36,608	May 16 04:17 PM
Nusse Roeland	Director	Mar 07 '24	Sale	76.98	10,400	800,627	43,097	Mar 11 04:04 PM
Hippel James	CFO	Dec 19 '23	Option Exercise	31.26	47,289	1,478,254	104,850	Dec 21 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TECH

Bio-Techne Corp

Upgrade your FINVIZ experience